Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trial.
Simone BerettaA VersaceB MartiniM ViganòS DiamantiC PiniG PaternòD CaroneJ MarianiL MonzaM RivaG PadovanoE RossiG CiterioG CastoldiF PadelliI GiachettiD AquinoC GiussaniE P SganzerlaC FerraresePublished in: European journal of neurology (2020)
Application of HDT15° in the hyperacute phase of experimental intracerebral hemorrhage does not worsen early outcome. Further research is needed to implement HDT15° as an emergency collateral therapeutic for acute stroke.